215 related articles for article (PubMed ID: 30087012)
1. Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks.
Brauer A; Waheed S; Singh T; Maursetter L
J Ren Nutr; 2019 Mar; 29(2):156-162. PubMed ID: 30087012
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
Chan MW; Cheah HM; Mohd Padzil MB
Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
[TBL] [Abstract][Full Text] [Related]
3. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.
Tsai WC; Yang JY; Luan CC; Wang YJ; Lai YC; Liu LC; Peng YS
Clin Exp Nephrol; 2016 Oct; 20(5):815-821. PubMed ID: 26658792
[TBL] [Abstract][Full Text] [Related]
4. Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
Yin J; Yin J; Lian R; Li P; Zheng J
BMC Nephrol; 2021 Jul; 22(1):243. PubMed ID: 34210293
[TBL] [Abstract][Full Text] [Related]
5. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
[TBL] [Abstract][Full Text] [Related]
6. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
[TBL] [Abstract][Full Text] [Related]
7. Patient empowerment in the management of hyperphosphatemia.
Kuhlmann MK; Hoechst S; Landthaler I
Int J Artif Organs; 2007 Nov; 30(11):1008-13. PubMed ID: 18067103
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series.
Moroșan E; Popovici V; Elian V; Dărăban AM; Rusu AI; Licu M; Mititelu M; Karampelas O
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981958
[TBL] [Abstract][Full Text] [Related]
9. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
[TBL] [Abstract][Full Text] [Related]
10. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
[TBL] [Abstract][Full Text] [Related]
11. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
[TBL] [Abstract][Full Text] [Related]
12. Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.
Edmonston DL; Isakova T; Dember LM; Brunelli S; Young A; Brosch R; Beddhu S; Chakraborty H; Wolf M
Am J Kidney Dis; 2021 Jun; 77(6):920-930.e1. PubMed ID: 33279558
[TBL] [Abstract][Full Text] [Related]
13. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
[TBL] [Abstract][Full Text] [Related]
14. Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders.
Sherman RA
Am J Kidney Dis; 2016 Feb; 67(2):182-6. PubMed ID: 26508681
[TBL] [Abstract][Full Text] [Related]
15. Phosphorus Counting Table for the control of serum phosphorus levels without phosphate binders in hemodialysis patients.
Bertonsello-Catto VR; Lucca LJ; da Costa JAC
Clin Nutr ESPEN; 2019 Aug; 32():153-157. PubMed ID: 31221281
[TBL] [Abstract][Full Text] [Related]
16. Phosphate Binders and Targets Over Decades: Do We have it Right Now?
Marcuccilli M; Chonchol M; Jovanovich A
Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444
[TBL] [Abstract][Full Text] [Related]
17. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants.
Van Camp YP; Vrijens B; Abraham I; Van Rompaey B; Elseviers MM
J Nephrol; 2014 Dec; 27(6):673-9. PubMed ID: 24563270
[TBL] [Abstract][Full Text] [Related]
18. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status.
Lopes AA; Tong L; Thumma J; Li Y; Fuller DS; Morgenstern H; Bommer J; Kerr PG; Tentori F; Akiba T; Gillespie BW; Robinson BM; Port FK; Pisoni RL
Am J Kidney Dis; 2012 Jul; 60(1):90-101. PubMed ID: 22385781
[TBL] [Abstract][Full Text] [Related]
19. Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.
Savica V; Calò LA; Monardo P; Davis PA; Granata A; Santoro D; Savica R; Musolino R; Comelli MC; Bellinghieri G
J Am Soc Nephrol; 2009 Mar; 20(3):639-44. PubMed ID: 19020004
[TBL] [Abstract][Full Text] [Related]
20. [Hyperphosphatemia in dialysis: which binder?].
Alfieri C; Malberti F; Mazzaferro S; Gallieni M; Russo D; Messa P; Cozzolino M
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
